A Safety and Efficacy Study of Allogeneic CAR Gamma-Delta T Cells in Subjects with Relapsed/Refractory Solid Tumors
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Solid Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
China Medical University Hospital, Taichung, Non-US, Taiwan
Contact: Study coordinator (Tao-Wei Ke, MD)
Study leads
Wen-Liang Huang, MD
Study Chair
Ever Supreme Bio Technology Co., Ltd.